Document 0108 DOCN M95B0108 TI Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. DT 9511 AU Harmsen MC; Swart PJ; de Bethune MP; Pauwels R; De Clercq E; The TH; Meijer DK; Department of Immunology, University of Groningen, Netherlands. SO J Infect Dis. 1995 Aug;172(2):380-8. Unique Identifier : AIDSLINE MED/95348535 AB Native and chemically derivatized proteins purified from serum and milk were assayed in vitro to assess their inhibiting capacity on the cytopathic effect of human immunodeficiency virus (HIV)-1 and human cytomegalovirus (HCMV) on MT4 cells and fibroblasts, respectively. Only native and conformationally intact lactoferrin from bovine or human milk, colostrum, or serum could completely block HCMV infection (IC50 = 35-100 micrograms/mL). Moreover, native lactoferrin also inhibited the HIV-1-induced cytopathic effect (IC50 = 40 micrograms/mL). When negatively charged groups were added to lactoferrin by succinylation, there was a 4-fold stronger antiviral effect on HIV-1, but the antiviral potency for HCMV infection was mostly decreased. Lactoferrin likely exerts its effect at the level of virus adsorption or penetration (or both), because after HCMV penetrated fibroblasts, the ongoing infection could not be further inhibited. DE Animal Blood Proteins/*PHARMACOLOGY Cattle Cells, Cultured Comparative Study Cytomegalovirus/*DRUG EFFECTS Cytopathogenic Effect, Viral DNA Replication/DRUG EFFECTS Embryo Female Fibroblasts Glycoproteins/PHARMACOLOGY Human HIV-1/*DRUG EFFECTS Lactoferrin/*PHARMACOLOGY Lung/DRUG EFFECTS/PATHOLOGY/VIROLOGY Milk Proteins/*PHARMACOLOGY Pregnancy Support, Non-U.S. Gov't Virus Inhibitors/*PHARMACOLOGY Virus Replication/DRUG EFFECTS JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).